Search results
Showing 1451 to 1500 of 3765 results for treatment
ng123/resources). If you have not been referred to a specialist mesh complication treatment centre, but you are concerned about symptoms...
people with metastatic colorectal cancer in the lung amenable to local treatment? Any explanatory notes(if applicable) Why the committee...
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG578)
Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia.
Summary of the evidence on alprostadil cream for treating erectile dysfunction to inform local NHS planning and decision-making
This guideline covers the identification, assessment and treatment of attachment difficulties in children and young people up to age 18 who are adopted from care, in special guardianship, looked after by local authorities in foster homes (including kinship foster care), residential settings and other accommodation, or on the edge of care. It aims to address the many emotional and psychological needs of children and young people in these situations, including those resulting from maltreatment.
This guideline covers care during labour and birth for women who need extra support because they have a medical condition or complications in their current or previous pregnancy. The guideline also covers women who have had no antenatal care. It aims to improve experiences and outcomes for women and their babies.
ces). If you have not been referred to a specialist mesh complication treatment centre, but you are concerned about symptoms you think...
Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making
encourages further research into percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain....
Summary of the evidence on green tea (Camellia sinensis) leaf extract 10% ointment for treating external genital and perianal warts to inform local NHS planning
Middle meningeal artery embolisation for chronic subdural haematomas
In development Reference number: GID-IPG10440 Expected publication date: TBC
Middle meningeal artery embolisation for chronic subdural haematomas: draft scope consultation
We are listening to your views on this Interventional procedures guidance. Comments close 7 January 2026.
head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment...
Orthostatic hypotension due to autonomic dysfunction: midodrine (ESNM61)
Summary of the evidence on midodrine for orthostatic hypotension due to autonomic dysfunction to inform local NHS planning and decision-making
Evidence-based recommendations on Sleepio to treat insomnia and insomnia symptoms.
blood cancer treatment recommended by NICE People with a rare and aggressive blood cancer will benefit from a potentially life saving...
In development Reference number: GID-TA11422 Expected publication date: TBC
In development Reference number: GID-TA11468 Expected publication date: 14 May 2026
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease (HTG405)
Evidence-based recommendations on Spectra Optia for automated red blood cell exchange in people with sickle cell disease.
User guide for the cost comparison company evidence submission template (PMG32)
This user guide describes how to submit evidence to NICE when a cost-comparison case is made as part of the fast track technology appraisal process. It explains what information NICE requires and the format in which it should be presented
Question NICE considered that more research is needed to establish the treatment sequence for vemurafenib and ipilimumab in patients who...
Antimicrobial stewardship: changing risk-related behaviours in the general population (NG63)
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includes measures to prevent and control infection that can stop people needing antimicrobials or spreading infection to others. It aims to change people’s behaviour to reduce antimicrobial resistance and the spread of resistant microbes.
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
Endo-SPONGE for treating low rectal anastomotic leak (HTG605)
Evidence-based recommendations on Endo-SPONGE for treating low rectal anastomotic leak.
Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment (ESUOM7)
Summary of the evidence on 0.2% topical glyceryl trinitrate ointment for chronic anal fissure to inform local NHS planning and decision-making
NICE encourages further research into percutaneous electrothermal treatment of the intervertebral disc annulus. Further research should...
This quality standard covers the care of pregnant women or pregnant people who are considering having or may need to have a caesarean birth, including those who have had a caesarean birth in the past. It includes decision making, reducing the risk of complications and care after a caesarean birth. It describes high-quality care in priority areas for improvement.
View quality statements for QS32Show all sections
Sections for QS32
- Quality statements
- Quality statement 1: Vaginal birth after a caesarean birth
- Quality statement 2: Request for a caesarean birth: maternity team involvement
- Quality statement 3: Request for a caesarean birth: anxiety
- Quality statement 4: Consultant obstetrician involvement in decision making for planned caesarean birth
- Quality statement 5: Timing of planned caesarean birth
- Quality statement 6: Consultant obstetrician involvement in decision making for unplanned caesarean birth
- Quality statement 7: The use of fetal blood sampling
and support: How does each step in the care pathway for prevention and treatment of early-onset neonatal infection impact on babies and...
This guide provides an overview of the principles and methods of health technology assessment and appraisal within the context of the NICE appraisal process
Evidence-based recommendations on 2 adjunctive colposcopy technologies (the DYSIS colposcope with DYSISmap and the ZedScan I) for assessing suspected cervical abnormalities in people having colposcopy.
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic non-small-cell-lung cancer.
This indicator covers the percentage of patients with diabetes with moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM158
This guideline covers diagnosing and managing drug allergy in all age groups. It aims to make it easier for professionals to tell when someone is having an allergic reaction, by specifying the key signs and patterns to look out for. It also makes recommendations on improving people’s understanding of their drug allergies, and ensuring these are recorded properly in their medical records.
efficacy and cost effectiveness of rehabilitation services compared with treatment as usual for people with complex psychosis with...
Recommendation ID NG81/6 Question Treatment for people with an IOP of 22 or 23 mmHg:- What is the clinical and cost effectiveness of...
thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19? Any explanatory notes(if applicable)...
assess the effectiveness of treatment options for bile acid diarrhoea. Consideration should be given to how well the...
with GORD that does not respond to optimal proton pump inhibitor (PPI) treatment? Any explanatory notes(if applicable) Current evidence...
This indicator covers the percentage of patients with diabetes without moderate or severe frailty, on the register, in whom the last IFCC-HbA1c is 58 mmol/mol or less in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM157
radiotherapy compared with standard radiotherapy in the postoperative treatment of metastatic spinal cord compression (MSCC)? Any...
pharmacological interventions compared with either intervention alone in the treatment of adults with social anxiety disorder? Any...
collecting further data on the impact of the automated devices on time to treatment for people with leg ulcers to reduce uncertainty in...
Targeted interventions to support and improve decision-making capacity for treatment:- What is the effectiveness and cost effectiveness...
restraint:- For people using adult mental health services, how is compulsory treatment and 'control and restraint' used in different...
Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making
Recommendation ID CG137/4 Question Treatment of convulsive status epilepticus (that is, not just refractory): What is the most effective
effectiveness for family intervention combined with individual CBT in the treatment of children and young people considered to be at...
Summary of the evidence on sildenafil for managing digital ulcers to inform local NHS planning and decision-making
Epilepsy syndromes: What are the initial and add-on AEDs of choice in the treatment of the epilepsy syndromes with onset in childhood,...
In development Reference number: GID-TA11488 Expected publication date: 15 July 2026